R. Wise

947 total citations
26 papers, 745 citations indexed

About

R. Wise is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, R. Wise has authored 26 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 8 papers in Molecular Biology and 7 papers in Molecular Medicine. Recurrent topics in R. Wise's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Inflammatory mediators and NSAID effects (6 papers). R. Wise is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Inflammatory mediators and NSAID effects (6 papers). R. Wise collaborates with scholars based in United States, United Kingdom and China. R. Wise's co-authors include Bernard B. Davis, Terry V. Zenser, J. M. Andrews, Melisa Cooper, Fred F. Kadlubar, W. Gibson Wood, Richard Matthews, J. P. Ashby, H. J. Armbrecht and Michael B. Mattammal and has published in prestigious journals such as Environmental Health Perspectives, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R. Wise

25 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Wise United States 15 224 203 171 129 96 26 745
Ibrahim A. Maghrabi Saudi Arabia 19 89 0.4× 355 1.7× 43 0.3× 123 1.0× 72 0.8× 41 1.2k
Md. Moniruzzaman Bangladesh 19 84 0.4× 246 1.2× 68 0.4× 115 0.9× 26 0.3× 68 1.0k
Anabela Almeida Portugal 14 219 1.0× 142 0.7× 108 0.6× 23 0.2× 59 0.6× 38 1.1k
Rosanna Mallamaci Italy 18 91 0.4× 281 1.4× 32 0.2× 55 0.4× 70 0.7× 48 1.0k
Katherine Z. Sanidad United States 20 74 0.3× 454 2.2× 58 0.3× 231 1.8× 79 0.8× 33 1.1k
Sedef Kır Türkiye 18 326 1.5× 376 1.9× 34 0.2× 27 0.2× 59 0.6× 63 1.1k
Maria-Georgia Ștefan Romania 13 54 0.2× 156 0.8× 198 1.2× 72 0.6× 35 0.4× 19 764
M. M. Husain India 13 160 0.7× 240 1.2× 20 0.1× 19 0.1× 24 0.3× 33 723
Tayyaba Afsar Saudi Arabia 22 100 0.4× 364 1.8× 47 0.3× 32 0.2× 30 0.3× 105 1.6k

Countries citing papers authored by R. Wise

Since Specialization
Citations

This map shows the geographic impact of R. Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Wise more than expected).

Fields of papers citing papers by R. Wise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Wise. The network helps show where R. Wise may publish in the future.

Co-authorship network of co-authors of R. Wise

This figure shows the co-authorship network connecting the top 25 collaborators of R. Wise. A scholar is included among the top collaborators of R. Wise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Wise. R. Wise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wise, R.. (2004). The relentless rise of resistance?. Journal of Antimicrobial Chemotherapy. 54(2). 306–310. 45 indexed citations
2.
Wise, R.. (2002). Antimicrobial resistance: priorities for action. Journal of Antimicrobial Chemotherapy. 49(4). 585–586. 227 indexed citations
3.
Boswell, F. J., J. M. Andrews, & R. Wise. (1996). BACTERICIDAL ACTIVITY OF TROVAFLOXACIN UNDER ANAEROBIC AND AEROBIC CONDITIONS. Infectious Diseases in Clinical Practice. 5. S113–S116. 6 indexed citations
4.
Cheng, A. F. B., et al.. (1993). The antimicrobial activity and β-lactamase stability of cefpirorae, a new fourth-generation cephalosporin in comparison with other agents. Journal of Antimicrobial Chemotherapy. 31(5). 699–709. 18 indexed citations
5.
Cooper, Melisa, J. M. Andrews, & R. Wise. (1992). In-vitro activity of PD 131628, a new quinolone antimicrobial agent. Journal of Antimicrobial Chemotherapy. 29(5). 519–527. 10 indexed citations
6.
Baldwin, David, J. M. Andrews, R. Wise, & D. Honeybourne. (1992). Bronchoalveolar distribution of cefaroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens. Journal of Antimicrobial Chemotherapy. 30(3). 377–385. 24 indexed citations
7.
Cooper, Melisa, J. M. Andrews, & R. Wise. (1992). In-vitro activity of tosufloxacin, a new quinolone antibacterial agent. Journal of Antimicrobial Chemotherapy. 29(6). 639–647. 3 indexed citations
8.
Cooper, Melisa, David Baldwin, Richard Matthews, J. M. Andrews, & R. Wise. (1991). In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibiotics. Journal of Antimicrobial Chemotherapy. 28(3). 407–413. 12 indexed citations
9.
Cooper, Melisa, J. M. Andrews, & R. Wise. (1991). Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions. Journal of Antimicrobial Chemotherapy. 28(3). 399–405. 17 indexed citations
10.
Cooper, Melisa, J. M. Andrews, J. P. Ashby, Richard Matthews, & R. Wise. (1990). In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. Journal of Antimicrobial Chemotherapy. 26(5). 667–676. 53 indexed citations
11.
Wise, R., Terry V. Zenser, John R. Rice, & Bernard B. Davis. (1986). Peroxidatic metabolism of benzidine by intact tissue: a prostaglandin H synthase-mediated process. Carcinogenesis. 7(1). 111–115. 14 indexed citations
12.
Wise, R., et al.. (1986). Metabolism of the renal carcinogen FNT by peroxidases. Carcinogenesis. 7(9). 1411–1414. 2 indexed citations
13.
Wise, R., Terry V. Zenser, & Bernard B. Davis. (1984). Characterization of benzidinediimine: a product of peroxidase metabolism of benzidine. Carcinogenesis. 5(11). 1499–1503. 28 indexed citations
14.
Wise, R., Terry V. Zenser, Fred F. Kadlubar, & Bernard B. Davis. (1984). Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase.. PubMed. 44(5). 1893–7. 66 indexed citations
15.
Zenser, Terry V., Samuel M. Cohen, Michael B. Mattammal, et al.. (1983). Prostaglandin hydroperoxidase-catalyzed activation of certain N-substituted aryl renal and bladder carcinogens. Environmental Health Perspectives. 49. 33–41. 19 indexed citations
16.
Zenser, Terry V., Michael B. Mattammal, R. Wise, J R Rice, & Bernard B. Davis. (1983). Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis.. Journal of Pharmacology and Experimental Therapeutics. 227(3). 545–550. 31 indexed citations
17.
Wise, R., Terry V. Zenser, & Bernard B. Davis. (1983). Peroxidase metabolism of the urinary bladder carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole.. PubMed. 43(4). 1518–22. 20 indexed citations
18.
Wise, R., Ron MacQuarrie, & Grace Y. Sun. (1979). In vivo desaturation of [1‐14C]stearate in the developing mouse brain. Journal of Neurochemistry. 33(1). 351–354. 1 indexed citations
19.
Wise, R., J. M. Andrews, & K. A. Bedford. (1975). The antimicrobial effect of combinations of clindamycin and metronidazole with spectinomycinn. Journal of Antimicrobial Chemotherapy. 1(4). 439–440. 2 indexed citations
20.
Campbell, R. H. & R. Wise. (1963). Determination of some mixed phenolic antioxidants in polyethylene. Journal of Chromatography A. 12. 178–182. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026